Revolution Medicines · 6 hours ago
Executive Director, Global Value, Access and Pricing, NSCLC
United States
Full-time
Remote
Director/Executive
$256K/yr - $320K/yr
15+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Executive Director will lead the development and execution of global market access and pricing strategies for NSCLC, collaborating with various teams to ensure optimal access and reimbursement outcomes across all regions.
Health CareLife ScienceMedical
Responsibilities
Formulate and define asset and disease area pricing and reimbursement strategies to support optimal access and reimbursement outcomes across all target regions. This includes asset global pricing architecture and launch sequencing strategy to develop net price corridors, reference pricing and value-based designs
Craft a differentiated global value proposition and oversee the development of the Global Value Dossier (GVD) and payer negotiation materials
Work closely with members of the Disease Area Strategy teams to help shape priority clinical development plans and combinations with both RevMed and oncology combination therapy opportunities
Design and implement strategic plans to support clinical development programs to ensure study designs, endpoints, and analyses generate the evidence needed for payer and HTA submissions including seeking systematic HTA advice
Identify and assess global market access risks and opportunities, integrating them into product strategies and reflecting them in Target Product Profiles (TPPs)
Partner with Clinical Development and Regulatory Affairs to incorporate payer and patient relevant evidence into clinical development strategies
Collaborate closely with the HEOR team to ensure alignment between market access needs and health economic research plans for pipeline assets
Engage with Regions to incorporate payer, policy insights and global trends into product access strategy
Lead global payer research and work with regions to gain actionable early engagement/advice from key HTA bodies (e.g., G-BA, NICE, HAS, AIFA, Chuikyo)
Develop and maintain strong business relationships with key functions responsible for value proposition enablement with a focus on Clinical, Commercial, Regulatory, Medical Affairs, and HEOR stakeholders
Prepare and submit HTA and reimbursement dossiers in priority markets with clear alignment to clinical and economic evidence plans
Partner with Medical Affairs, HEOR, Regulatory, and Clinical to align evidence generation with access and reimbursement needs
Build strong cross-funtional relations and build a high-performing team that coordinates closely with regional leads and country affiliates
Serve as a key leader within the global launch team, actively contributing to go-to-market planning, demand forecasting, and gross-to-net-scenario modeling
As required, represent the company externally with payers, HTA bodies, trade associations, and policy groups, helping shape access environments
Coordinate with the U.S. region to align on policy and legislation risks that could impact life cycle management pricing corridors
Qualification
Required
Bachelor's degree required; advanced degree in Pharmacy, Health Economics, Public Health, Life Sciences, or Business preferred (e.g., PharmD, PhD, MBA)
Minimum 15+ years of progressive leadership in market access, pricing, and HEOR within the biopharma industry
Demonstrated success launching a first-in-class or specialty therapy in ex-U.S. markets (especially Germany, France, and Japan)
Demonstrating the ability to build a new capability and framework to support a Global Market Access commercialization strategy
Established network of relationships with key stakeholders and organizations in Global Market Access landscape
Experience engaging HTA and payer organizations in early advice to inform development and trial strategies
Deep understanding of global payer systems and HTA processes, including AMNOG, Chuikyo, NICE, and other EU frameworks
Experience designing and implementing global pricing strategy, including value-based pricing, launch sequencing, and reference pricing mitigation
Proven ability to work cross-functionally and influence executive leadership in a dynamic, resource-constrained, early-stage company
Preferred
Prior experience with Ex-U.S. and U.S. legislation and public policies that impact Global and regional decisions (U.S. IRA, MFN, EU regulations etc.)
Familiarity with rare disease, or oncology product launches
Experience working with external vendors, consultants, and access agencies to develop payer research, modeling, and dossier development
Strong executive presence, with the ability to clearly articulate complex value stories to both internal and external stakeholders
Experience building or scaling global market access functions in a pre-commercial or newly commercial biotech company
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
2025-12-18
2025-12-18
Company data provided by crunchbase